159 related articles for article (PubMed ID: 2679837)
1. Therapeutic focus. The fluoroquinolones.
James DG
Br J Clin Pract; 1989 Feb; 43(2):66-7. PubMed ID: 2679837
[TBL] [Abstract][Full Text] [Related]
2. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
4. Quinolones for short-term treatment of uncomplicated urinary tract infection.
Kadiri S; Ajayi SO; Toki RA
East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
[TBL] [Abstract][Full Text] [Related]
5. The role of the fluoroquinolones.
Guay DR
Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
[TBL] [Abstract][Full Text] [Related]
6. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
7. [Urinary tract infections: risk factors and therapeutic trends].
Margariti PA; Astorri AL; Mastromarino C
Recenti Prog Med; 1997 Feb; 88(2):65-8. PubMed ID: 9148368
[TBL] [Abstract][Full Text] [Related]
8. [Fluoroquinolones: pharmacology, antibacterial spectrum and indications in pneumology].
Underner M; Grignon B; Roblot F; Meurice JC; Patte F
Rev Pneumol Clin; 1989; 45(1):14-22. PubMed ID: 2662344
[TBL] [Abstract][Full Text] [Related]
9. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolones: how to use (but not overuse) these antibiotics.
Sable CA; Scheld WM
Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
Paton JH; Reeves DS
Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
13. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
14. The fluoroquinolones for urinary tract infections: a review.
Cunha BA
Adv Ther; 1994; 11(6):277-96. PubMed ID: 10150268
[TBL] [Abstract][Full Text] [Related]
15. New classification and update on the quinolone antibiotics.
King DE; Malone R; Lilley SH
Am Fam Physician; 2000 May; 61(9):2741-8. PubMed ID: 10821154
[TBL] [Abstract][Full Text] [Related]
16. Role of fluoroquinolones in lower respiratory tract infections.
Vellend H
Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
[TBL] [Abstract][Full Text] [Related]
17. Microbiologic aspects of fluoroquinolones.
Neu HC
Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268
[TBL] [Abstract][Full Text] [Related]
18. [Quinolones: historic review].
Rothlin RP
Medicina (B Aires); 1999; 59 Suppl 1():3-7. PubMed ID: 10436548
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones.
Hendershot EF
Infect Dis Clin North Am; 1995 Sep; 9(3):715-30. PubMed ID: 7490440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
